Ipamorelin+sermorelin recalls

The FDA has published 1 recall involving Ipamorelin+sermorelin since 2019. The latest was reported on 20 Feb 2019. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2019

Last 12 months0reported

Class I00% of total

Ongoing0latest 20 Feb 2019

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why ipamorelin+sermorelin is recalled

Sterility1100%

Companies

Promise Pharmacy1100%

By year

20191100%

All ipamorelin+sermorelin recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
20 Feb 2019Drug	CLASS II	Ipamorelin+Sermorelin, 15mg/15mg, injection recalled by Promise Pharmacy	Promise Pharmacy	Sterility	Nationwide

Should you stop taking Ipamorelin+sermorelin?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.